@grandslam... Yes, sadly, there are way more paths to destruction in the biopharma world than there are to success. TBH, I never expected to be in this situation with this stock. When I started with it many years ago, I viewed it as a gamble on non-controversial stem cell therapies, which I expected to become a hot commodity after the controversies with embryonic stem cells in the mid to late oughts. Unfortunately, that never happened. Instead, the industry was saturated with charlatans who were damaging people and ripping people off. VB always struck me as different (which it is), but it had to deal with serious headwinds rather than the rapidly rising tide that I expected so long ago. It's really amazing, and a testament to Musick's commitment, that it survived through all that. If they can pull off the IPO as stated, it will be a truly remarkable survival story. But I expected a run on the stock a decade ago, which never happened.
As for how they have treated shareholders over the past few years, I think that can be summed up in two words: Jack Zamora. What a joke, IMHO. Except it isn't funny, given what he did to the equity structure, and failed to do as CEO. I could be totally wrong about the guy, but all I can do is react to the info they release. And what I see is an empty suit. As far as I can tell, he's a cosmetologist with a medical degree, not a corporate executive. If I'm wrong, I'd love to see the evidence.
But it's water under the bridge. I did not expect that they would pull off an IPO, particularly given the awful corporate presentation document from last year. I expected (and wrote about) the kind of IPO that I thought might be realistic, which is what they are actually doing now.. And it seems they finally hired the right guy to make it happen. And we'll see if he can complete the job he was hired to do. It would be nice if they would give us a brief update. I understand the need to not violate any SEC rules, but a simple "everything is on track" kind of release would be nice to see.
